|4May 19, 7:43 PM ET

Beckman Richard 4

4 · Adverum Biotechnologies, Inc. · Filed May 19, 2022

Insider Transaction Report

Form 4
Period: 2022-05-17
Beckman Richard
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-05-17$0.82/sh+10,000$8,22810,000 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION